Abstract:Objective :— This study is to explore the effect of valsartan-eluting stents on neointima formation after stenting and to elucidate possible mechanisms how locally used valsartan prevents in-stent restenosis (ISR). METHOD: valsartan- and carriereluting stents were manufactured by using multi-layer-coated technology. Bare stents, carrier-eluting stents and valsartan– eluting stents were implanted into the abdominal aortas of the rabbits respectively. Quantitative angiography (QA) before, immediately after and 3 months after stent implantation were compared between the groups of bare (n=8), carrier-eluting (n=8) and valsartan-eluting stent (n=10), which allows the comparison of vascular diameters of aortas as well as indices of vascular neointimal formation, i.e. luminal area (LA), neointimal area (NIA), inner elastic membrane luminal area (IELA) and the maximal inner-membrane thickness (MIT) in 15 rabbits. α-Actin protein expression were detected by Envision two-step immunohistochemistry. Mean positive indices (MPI) of the above protein were analyzed semi-quantatively by IMS(Information Management System) cell image analysis system. MPI=positive area×OD (optical density). Collagen deposition in neointima was observed through MASSON stain among the three groups. Result:— the mean aortic diameters were similar in the three groups:bare stents group(n=8), carrier-eluting stents group(n=8) and valsartan eluting stents group(n=10) measured by QA at different time. A larger luminal area and a less neointimal hyperplasia in valsartan eluting-stents group was found compared with the other two groups. The mean luminal areas were 4345548±125822um2; 4302061±167952 um2; 5016269±207934um2 respectively. The mean neointimal areas were 1119635±163503um2; 1135636±136555um2; 441577±74099um2 and the mean maximal inner-membrane thickness were 210±30um;192±21um; 116±12um respectively. α-Actin protein expression was significantly lower in neointima of valsartan eluting-stents group than the other two groups. Through MASSON stain we found that Collagen was much richer in neointima of bare stents group and carrier-eluting stents group than valsartan eluting-stents group. Conclusion:— Valsartan eluting-stents inhibited neointimal hyperplasia after stenting by decreasing collagen deposition and smooth muscle cell proliferation. Therefore it would be potentially effective in preventing in-stent restenosis. Abbreviations:— Quantitative angiography (QA), luminal area (LA), neointimal area (NIA), inner elastic membrane luminal area (IELA), the maximal inner-membrane thickness (MIT), Mean positive indices (MPI), optical density (OD), Drugeluting stents (DES), in-stent restenosis(ISR), percutaneous transluminal coronary angioplasty (PTCA), angiotensin α type 2 receptor (AT2).

Impact of Blood Circulation on Reendothelialization, Restenosis and Atrovastatin's Restenosis Prevention Effects

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

Endothelial Progenitor Cells and In-stent Restenosis.

Has collateral blood flow any effect on restenosis rate? Our experience

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Effect of Resveratrol on Reendothelialization and Neointimal Formation in Intimal Injury Model

Atorvastatin Preconditioning Improves the Forward Blood Flow in the No‐reflow Rats

Effects of Resveratrol on Endothelial Progenitor Cells and Their Contributions to Reendothelialization in Intima-Injured Rats

Effects of different positions of intravascular stent implantation in stenosed vessels on in-stent restenosis: An experimental and numerical simulation study

Atorvastatin Increases Endothelial Progenitor Cells in Balloon-Injured Mouse Carotid Artery.

Impact of high loading-dose atorvastatin pre-treatment before primary percutaneous coronary intervention on coronary flow in patients with ST segment elevation myocardial infarction

Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia

Role of Endothelial Nitric Oxide Synthase and Vagal Activity in the Endothelial Protection of Atorvastatin in Ischemia/Reperfusion Injury

The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study

Effect Of Recombinant Human Sdf-1a On Re-Endothelialization After Sirolimus-Eluting Stent Implantation In Rabbit Aorta Abdominalis

Effects of Certain Vasoactive Peptides on Pathogenesis of Vascular Restenosis.

Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention

Influence of Valsartan-Eluting Stent on Neointima Formation

Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury

Nanoparticle-based Approaches for Treating Restenosis after Vascular Injury